Bausch Health Q3 Revenue Beats Estimates on Salix, Solta Demand
Bausch Health's third-quarter revenue exceeded estimates, supported by demand for Salix and Solta.
Bausch Health's third-quarter revenue exceeded estimates, supported by demand for Salix and Solta.